
Suturion has signed a new distribution agreement with Mediplast, a leading European Life Science partner and part of the AddLife Group. The agreement covers Sweden, Norway, Denmark, Finland, Iceland, Belgium, Luxembourg, and the Netherlands. Together, we will bring SutureTOOL™ to hospitals and healthcare providers across these markets, combining Mediplast’s expertise, trusted network, and local knowledge with our innovative fascia closure solution.
“Mediplast is a highly experienced MedTech partner, combining deep knowledge of local markets with an understanding of clinical needs. This partnership positions us to drive long-term, sustainable growth and expand access to SutureTOOL™ across Northern Europe.”
- Sophia Verheij-Engqvist, Sales Director EMEA, Suturion.
“Partnering with Suturion is a natural fit for Mediplast, as SutureTOOL™ strengthens our portfolio with an innovative solution for safe and efficient fascia closure. By adding this technology, we help deliver tangible value to healthcare professionals and, ultimately, to patients across Northern Europe. We are proud to support the introduction of a tool that improves outcomes while standardizing abdominal wall closure in everyday clinical practice.”
- Hans Wallén, Sales and Marketing Director, Mediplast.
This collaboration enables more surgeons to perform abdominal wall closure more quickly, safely, and consistently, ultimately improving patient outcomes and advancing everyday surgical care.


